UBS AM’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.78M | Buy |
308,139
+63,804
| +26% | +$783K | ﹤0.01% | 1835 |
|
2025
Q1 | $5.37M | Buy |
244,335
+45,693
| +23% | +$1M | ﹤0.01% | 1532 |
|
2024
Q4 | $4.51M | Buy |
198,642
+28,457
| +17% | +$645K | ﹤0.01% | 1656 |
|
2024
Q3 | $3.09M | Sell |
170,185
-466
| -0.3% | -$8.47K | ﹤0.01% | 1804 |
|
2024
Q2 | $4.97M | Buy |
170,651
+53,412
| +46% | +$1.56M | ﹤0.01% | 1492 |
|
2024
Q1 | $4.16M | Sell |
117,239
-257
| -0.2% | -$9.11K | ﹤0.01% | 1338 |
|
2023
Q4 | $5.12M | Hold |
117,496
| – | – | ﹤0.01% | 1231 |
|
2023
Q3 | $4.49M | Buy |
117,496
+1,334
| +1% | +$50.9K | ﹤0.01% | 1253 |
|
2023
Q2 | $6.67M | Hold |
116,162
| – | – | ﹤0.01% | 1112 |
|
2023
Q1 | $6.67M | Buy |
116,162
+15,512
| +15% | +$891K | ﹤0.01% | 1112 |
|
2022
Q4 | $5.64M | Buy |
100,650
+8,741
| +10% | +$490K | ﹤0.01% | 1129 |
|
2022
Q3 | $3.89M | Sell |
91,909
-22,360
| -20% | -$947K | ﹤0.01% | 1288 |
|
2022
Q2 | $6.17M | Buy |
114,269
+1,936
| +2% | +$105K | ﹤0.01% | 1138 |
|
2022
Q1 | $7.22M | Buy |
112,333
+6,995
| +7% | +$449K | ﹤0.01% | 1195 |
|
2021
Q4 | $7.06M | Sell |
105,338
-2,967
| -3% | -$199K | ﹤0.01% | 1255 |
|
2021
Q3 | $7.42M | Buy |
108,305
+510
| +0.5% | +$34.9K | ﹤0.01% | 1204 |
|
2021
Q2 | $7.36M | Buy |
107,795
+1,836
| +2% | +$125K | ﹤0.01% | 1221 |
|
2021
Q1 | $7.32M | Sell |
105,959
-11,034
| -9% | -$762K | ﹤0.01% | 1191 |
|
2020
Q4 | $7.6M | Buy |
116,993
+15,896
| +16% | +$1.03M | ﹤0.01% | 1146 |
|
2020
Q3 | $4.77M | Buy |
101,097
+5,509
| +6% | +$260K | ﹤0.01% | 1162 |
|
2020
Q2 | $4.49M | Sell |
95,588
-2,573
| -3% | -$121K | ﹤0.01% | 1159 |
|
2020
Q1 | $4.38M | Buy |
98,161
+9,486
| +11% | +$424K | ﹤0.01% | 1091 |
|
2019
Q4 | $5.17M | Sell |
88,675
-9,388
| -10% | -$547K | ﹤0.01% | 1172 |
|
2019
Q3 | $5.89M | Buy |
98,063
+11,582
| +13% | +$696K | ﹤0.01% | 1144 |
|
2019
Q2 | $4.83M | Buy |
86,481
+5,040
| +6% | +$281K | ﹤0.01% | 1216 |
|
2019
Q1 | $4.54M | Buy |
81,441
+5,436
| +7% | +$303K | ﹤0.01% | 1189 |
|
2018
Q4 | $3.43M | Buy |
76,005
+5,057
| +7% | +$228K | ﹤0.01% | 1218 |
|
2018
Q3 | $4.67M | Buy |
70,948
+3,691
| +5% | +$243K | ﹤0.01% | 1161 |
|
2018
Q2 | $4.33M | Buy |
67,257
+13,811
| +26% | +$890K | ﹤0.01% | 1209 |
|
2018
Q1 | $2.96M | Buy |
53,446
+5,917
| +12% | +$327K | ﹤0.01% | 1310 |
|
2017
Q4 | $2.27M | Buy |
47,529
+2,745
| +6% | +$131K | ﹤0.01% | 1379 |
|
2017
Q3 | $2.26M | Buy |
44,784
+1,753
| +4% | +$88.5K | ﹤0.01% | 1351 |
|
2017
Q2 | $2.35M | Buy |
43,031
+3,124
| +8% | +$170K | ﹤0.01% | 1298 |
|
2017
Q1 | $1.68M | Sell |
39,907
-5,449
| -12% | -$230K | ﹤0.01% | 1417 |
|
2016
Q4 | $1.95M | Sell |
45,356
-12,998
| -22% | -$558K | ﹤0.01% | 1298 |
|
2016
Q3 | $2.41M | Sell |
58,354
-6,974
| -11% | -$288K | ﹤0.01% | 1307 |
|
2016
Q2 | $2.61M | Sell |
65,328
-18,852
| -22% | -$752K | ﹤0.01% | 1260 |
|
2016
Q1 | $2.84M | Sell |
84,180
-6,198
| -7% | -$209K | ﹤0.01% | 1225 |
|
2015
Q4 | $3.06M | Buy |
90,378
+1,588
| +2% | +$53.8K | ﹤0.01% | 1242 |
|
2015
Q3 | $2.64M | Buy |
88,790
+6,968
| +9% | +$207K | ﹤0.01% | 1297 |
|
2015
Q2 | $2.25M | Sell |
81,822
-11,102
| -12% | -$306K | ﹤0.01% | 1352 |
|
2015
Q1 | $2.34M | Sell |
92,924
-1,564
| -2% | -$39.4K | ﹤0.01% | 1298 |
|
2014
Q4 | $2.1M | Buy |
94,488
+75,650
| +402% | +$1.68M | ﹤0.01% | 1305 |
|
2014
Q3 | $382K | Hold |
18,838
| – | – | ﹤0.01% | 2012 |
|
2014
Q2 | $362K | Hold |
18,838
| – | – | ﹤0.01% | 2075 |
|
2014
Q1 | $354K | Buy |
18,838
+1,468
| +8% | +$27.6K | ﹤0.01% | 2075 |
|
2013
Q4 | $339K | Sell |
17,370
-1,468
| -8% | -$28.7K | ﹤0.01% | 2041 |
|
2013
Q3 | $310K | Hold |
18,838
| – | – | ﹤0.01% | 2065 |
|
2013
Q2 | $282K | Buy |
+18,838
| New | +$282K | ﹤0.01% | 2032 |
|